NCT06976346View on ClinicalTrials.gov

Relative Bioavailability Study of HRG2010 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 10, 2021

Primary Completion Date

October 7, 2021

Study Completion Date

October 7, 2021

Conditions

Parkinson's Disease

Interventions

DRUG

HRG2010 Capsule, Sinemet®, Madopar®

In each period under fasting conditions, subjects received oral administration of either HRG2010 Capsule dose 1, HRG2010 Capsule dose 2, Sinemet®, or Madopar®.

Trial Locations (1)

250000

Shandong Province Qianfoshan Hospital, Jinan

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT06976346 - Relative Bioavailability Study of HRG2010 in Healthy Subjects | Biotech Hunter | Biotech Hunter